NewAmsterdam’s obicetrapib holds potential to become first CETP inhibitor to advance to clinical practice: GlobalData Read more
Pfizer’s gene therapy for Haemophilia A receives positive topline results from Phase 3 Study Read more
Alembic gains USFDA final approval for Fluphenazine Hydrochloride Tablets USP, 1 mg, 2.5 mg, 5 mg, and 10 mg Read more